» Articles » PMID: 38687210

Alpha-chloralose Poisoning in 25 Cats: Clinical Picture and Evaluation of Treatment with Intravenous Lipid Emulsion

Overview
Date 2024 Apr 30
PMID 38687210
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The aims of this study were to describe the clinical picture and progression in cats with alpha-chloralose (AC) intoxication and to determine if treatment with intravenous (IV) lipid emulsion (ILE) influenced either the serum concentration of AC or the clinical signs.

Methods: Cats with suspected AC poisoning admitted to a university small animal hospital were included. The cats were randomised into two groups: one receiving 20% ILE at a dose of 300 mg/kg as a 2 min bolus, followed by a 1500 mg/kg continuous rate infusion over 30 mins (IL+ group) and the other receiving IV fluid therapy with Ringer's acetate (IL- group). Serum samples were drawn at 0, 2, 12 and 24 h after admission. Samples were tested for AC with a novel validated, quantitative, ultra-high-performance liquid chromatography-tandem mass spectrometry method. Vital and predefined clinical signs were noted at the times of sampling and patients were scored using a previously described intoxication severity score. Telephone interviews were conducted after discharge to assess outcome.

Results: A total of 25 cats were enrolled: 13 cats in the IL+ group and 12 in the IL- group. The most common clinical signs at presentation were tremor (n = 22, 88.0%), cranial nerve deficits (n = 20, 80.0%) and bradycardia (n = 19, 76.0%). No significant difference in AC concentration or change in intoxication score over time was found between the IL+ and IL- groups at any time point ( >0.05). All cats recovered within 72 h.

Conclusions And Relevance: ILE did not have any effect on the AC serum concentration or clinical signs in AC-poisoned cats. All cats survived until follow-up. In cats with an acute onset of the described neurological signs, AC intoxication is an important differential diagnosis with an excellent prognosis.

Citing Articles

Lipid emulsion dosage for treatment as an adjuvant drug in the cat.

Sohn J, Lundgren S J Feline Med Surg. 2024; 26(8):1098612X241267181.

PMID: 39212593 PMC: 11418618. DOI: 10.1177/1098612X241267181.


Clinical effects and adverse effects of intravenous lipid emulsion treatment in dogs and cats with suspected poisoning.

Kiwitz D, Markert C, Dorfelt R PLoS One. 2024; 19(5):e0298828.

PMID: 38809887 PMC: 11135785. DOI: 10.1371/journal.pone.0298828.

References
1.
Segev G, Yas-Natan E, Shlosberg A, Aroch I . Alpha-chloralose poisoning in dogs and cats: a retrospective study of 33 canine and 13 feline confirmed cases. Vet J. 2006; 172(1):109-13. DOI: 10.1016/j.tvjl.2005.02.030. View

2.
Kaplan A, Whelan M . The use of IV lipid emulsion for lipophilic drug toxicities. J Am Anim Hosp Assoc. 2012; 48(4):221-7. DOI: 10.5326/JAAHA-MS-5761. View

3.
Kullmann F, Wells G, Langdale C, Zheng J, Thor K . Stability of the acetic acid-induced bladder irritation model in alpha chloralose-anesthetized female cats. PLoS One. 2013; 8(9):e73771. PMC: 3767621. DOI: 10.1371/journal.pone.0073771. View

4.
Markert C, Heilmann R, Kiwitz D, Doerfelt R . Intravenous lipid emulsion for the treatment of poisonings in 313 dogs and 100 cats (2016-2020). Front Vet Sci. 2023; 10:1272705. PMC: 10568331. DOI: 10.3389/fvets.2023.1272705. View

5.
BALIS G, MONROE R . The pharmacology of chloralose. A review. Psychopharmacologia. 1964; 6(1):1-30. DOI: 10.1007/BF00710911. View